Vertex Pharmaceuticals Tokenized Stock (Reality) RVRTX
RVRTX
540.00
$
1.17 %
Change 24h
Market Cap
$ 4882.7
Volume 24h
$ 898.98
Circulating Supply
9
Total Supply
9
Website
Social
RVRTX
$
| # | Exchange | Pair | Price | Volume 24h |
|---|
Description
Vertex Pharmaceuticals is a U.S. biopharmaceutical enterprise engaged in the development and commercialization of prescription drugs. Its primary approved products are used to treat cystic fibrosis. Additionally, the company has clinical-stage product candidates in sickle cell disease, thalassemia, acute pain, and specific kidney diseases. The company combines internal R&D platforms with external corporate partnerships to advance the clinical validation and regulatory review processes of targeted therapies.